register

News & Trends - Medical Technology

Private health insurers take Australians for April Fools

Health Industry Hub | April 1, 2021 |
[Total: 2    Average: 4.5/5]

MedTech News: Private health insurance premiums have today increased by over 2.7%, the second increase in six months, with some Australian families being forced to face premium increases as high as 5.47% – a whopping six-times inflation.

Corporate health insurers are treating Australians like April Fools if they truly believe struggling families will cop a second hike in their premiums in the span of just six months, despite Australian Prudential Regulation Authority (APRA) data showing that in the three months to December 2020, insurers profits increased by 205.4%.

Despite raking in mega-covid-profits, the corporate health insurer’s lobby group, Private Healthcare Australia (PHA), claims “medical device prices are the largest driver of the 1 April premium increases”. Unfortunately for PHA, those claims do not add up given medical device costs make up less than 10% of the benefits insurers are required to pay, as well as the fact the total cost of devices for insurers has decreased by 3.95% in 2020.

Medical Technology Association of Australia CEO, Ian Burgess, said the scare campaign by corporate health insurers is being used to distract from their unjustifiable back-to-back premium increases and to push the Federal Government into radical, so called, reforms that would abolish patient access and surgeon choice guaranteed by the Prostheses List.

“It’s hard to fathom how insurers can increase premiums on Australians by more than six-times inflation, rake in mega-profits of 205.4% in the last quarter, and still claim they’re doing it tough,” Mr Burgess said.

“Enough is enough, it’s time for corporate health insurers and their lobbyist at PHA to stop playing politics and come to the table with MTAA and work through real and meaningful solutions to ensure Australians have access to the life-saving and life-changing medical devices, chosen by their surgeons and not insurers.”

MTAA has joined with the Australian Medical Association (AMA), Australian Private Hospitals Association (APHA) and Consumer Health Forum (CHF) to issue a joint statement opposing the changes being pushed by corporate health insurers that would see the patient access and surgeon choice guarantee of the Prostheses List abolished and replaced with a managed care system where insurers would be able to influence what device a patient would or would not get access to.


About the author

About the author

The Health Industry Hub is Australia’s first & only One Stop Hub for the Life Sciences industry (Pharma, Medtech and Biotech) that connects the healthcare community and its key stakeholders through centralised and meaningful content, facilitates engagement and inspiration for collaboration to shape the future and enhance patient outcomes. Health Industry Hub" class="more" title="Link to full profile">Link to full profile

Leadership & Management

Leadership Management Qualities - The power of being an authentic leader

The power of being an authentic leader

Health Industry Hub | April 21, 2021 |

Leadership & Management: Welcome to Health Industry Hub’s Women in Leadership Series – connecting, engaging and empowering women in the […]

More


Digital & Innovation

Healthcare Technology Digital Innovations - Data is the biggest challenge, and opportunity, for MedTech

Data is the biggest challenge, and opportunity, for MedTech

Health Industry Hub | April 21, 2021 |

Digital & Innovation: Medical technology is increasingly shaping the future of healthcare. The sector is also a growing part of […]

More


News & Trends - Medical Technology

MedTech News - Thermo Fisher acquisition to better serve its pharma and biotech clients

Thermo Fisher acquisition to better serve its pharma and biotech clients

Health Industry Hub | April 21, 2021 |

MedTech News: Thermo Fisher Scientific is buying clinical research services provider PPD for a hearty $17.4 billion, and that’s not its only acquisition this […]

More


News & Trends - Pharmaceuticals

Pharma News - First-in-class oncology drug candidate licensed by Aussie pharma

First-in-class oncology drug candidate licensed by Aussie pharma

Health Industry Hub | April 21, 2021 |

Pharma News: An Australian oncology-focused drug development company entered into a worldwide exclusive licensing agreement and a master services agreement […]

More